751
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Letter in response to “The Vitamin B12 analog cobinamide is an effective hydrogen sulfide antidote in a lethal rabbit model”

, , &
Page 73 | Received 19 Sep 2014, Accepted 01 Oct 2014, Published online: 29 Nov 2014

References

  • Brenner M, Benavides S, Mahon SB, Lee J, Yoon D, Mukai D, et al. The Vitamin B12 analog cobinamide is an effective hydrogen sulfide antidote in a lethal rabbit model. Clin Toxicol 2014; 52:490–497.
  • Lindenmann J, Matzi V, Neuboeck N, Ratzenhofer-Komenda B, Maier A, Smolle-Juettner FM. Severe hydrogen sulphide poisoning treated with 4-dimethylaminophenol and hyperbaric oxygen. Diving Hyperb Med 2010; 8:213–217.
  • Lewis RJ, Schnatter AR, Drummond I, Murray N, Thompson FS, Katz AM, et al. Mortality and cancer morbidity in a cohort of Canadian petroleum workers. Occup Environ Med 2003; 8:918–928.
  • Schivanthan MC, Perera H, Jayasinghe S, Karunanayake P, Chang T, Ruwanpathirana S, et al. Hydrogen sulphide inhalational toxicity at a petroleum refinery in Sri Lanka: a case series of seven survivors following an industrial accident and a brief review of medical literature. Occup Environ Med 2013;8:9.
  • Lopez A, Prior MG, Reifenstein RJ, Goodwin LR. Peracute toxic effects of inhaled hydrogen sulfide and injected sodium hydrosulfide on the lungs of rats. Fundam Appl Toxicol 1989;12:367–373.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.